MiR-375 expression was significantly downregulated in gliomas; it could inhibit glioma growth by repressing the CTGF-epidermal growth factor receptor (EGFR) signaling pathway, thus inhibiting glioma proliferation, migration, and invasion. Here, CCN2 is linked to glioma.